CLINICAL_TRIALS ClinicalTrials.gov record with results posted

A Single-center, Phase 2 Open-label Trial Evaluating the Efficacy and Safety of OBINUTUZUMAB in Treatment of Immunosuppression-dependent or Immunosuppression/Treatment-resistant Primary FSGS, or Contraindication/Patient Refusal to Take High Dose Corticosteroids

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04983888
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-06-26T00:07:40.088498+00:00
Published At: 2026-06-25T00:00:00+00:00
Record Updated At: 2026-06-25
Results Posted At: 2026-06-25
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Primary Focal Segmental Glomerulosclerosis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-06-25"
protocolSection.identificationModule.nctId: "NCT04983888"
protocolSection.identificationModule.officialTitle: "A Single-center, Phase 2 Open-label Trial Evaluating the Efficacy and Safety of OBINUTUZUMAB in Treatment of Immunosuppression-dependent or Immunosuppression/Treatment-resistant Primary FSGS, or Contraindication/Patient Refusal to Take High Dose Corticosteroids"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2026-06-25"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.